Cooperative Agreement HU00012520026
Award Date
3/17/25
Completion Date
3/16/26
Dollars Obligated
$847K
Federal Agency
Uniformed Services University of the Health Sciences
Awardee
Metis Foundation (CYYCLBFLP125)
Federal Grant Program
12.750
Assistance Type
Cooperative Agreement
Place of Performance
Bethesda, MD 20814, USA
Similar Awards
The Metis Foundation was awarded a $4,241,538 Cooperative Agreement under the Uniformed Services University Medical Research Projects program (CFDA 12.750) by the Department of Defense Uniformed Services University of the Health Sciences. The award, titled "Military Cardiovascular Outcomes Research (MICOR) Core", has a performance period from December 1, 2024 to November 30, 2027. As a non-profit organization with expertise in military medical research, Metis Foundation will deliver...
This Cooperative Agreement award, with a total funding amount of $2,693,485, was issued by the Uniformed Services University of Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750). The award supports the Military Cardiovascular Outcomes Research (MICOR) project, which will be conducted by the Metis Foundation, a non-profit research organization, with a performance period from February 1, 2024 to August 31, 2025. Through this funding, the...
This $2,700,213 Cooperative Agreement award from the Uniformed Services University of Health Sciences, under the Uniformed Services University Medical Research Projects program (CFDA 12.750), supports the MILITARY CARDIOVASCULAR OUTCOMES RESEARCH (MICOR) ELECTROCARDIOGRAM RISK ASSESSMENT TO PREVENT SUDDEN CARDIAC EVENTS (ERASE) PROGRAM. The prime awardee, Metis Foundation, is a non-profit organization with extensive experience providing medical research, education, and project management...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,845,076 to the Metis Foundation to develop novel therapeutics that target innate immune responses for treating multiple organ failure in severe polytrauma during prolonged casualty care. The award period runs from November 1, 2024 to October 31, 2027.
Metis Foundation, a non-profit organization specializing in military medical research and development,...
This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
The Metis Foundation will receive a $6.6 million cooperative agreement award from the Uniformed Services University of the Health Sciences (USUHS) to conduct a randomized controlled trial of ivabradine in long-haul COVID-19 patients. The award is part of USUHS's Uniformed Services University Medical Research Projects program (CFDA 12.750) and will run from September 2021 through August 2025. As part of the trial, The Metis Foundation will evaluate the safety and efficacy of ivabradine in...
The Defense Health Agency awarded a $398,107 Cooperative Agreement to the Metis Foundation, a non-profit organization, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year project to develop a multi-modal approach to reduce vascularized composite allotransplantation (VCA) immunogenicity and improve functional outcomes. The Metis Foundation has an extensive history providing medical research, products, and services through prime and sub...
The Defense Health Agency awarded a $264,000 cooperative agreement to the Metis Foundation from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program (CFDA 12.420). The award will support the Metis Foundation's ACTIVE REJECTION MICRO-PATCH SURVEILLANCE (ARMS) SYSTEM FOR VASCULARIZED COMPOSITE ALLOGRAFTS project located in San Antonio, TX. Through this funding, the Metis Foundation will develop an ARMS system to monitor vascularized composite...
The Cooperative Agreement award of $1,987,608.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Metis Foundation in improving severe burn resuscitation outcomes through the use of icatibant, an FDA-approved bradykinin B2 receptor antagonist. This 2-year project, running from September 2023 to September 2025, aims to develop innovative medical technologies and conduct research to transform care for military service...
This Project Grant award for $2,199,210.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), will support a prospective study by the Metis Foundation to evaluate the use of a suprasdrma dressing to promote healing and reduce the time to grafting of full-thickness wounds. The goal is to accelerate the return to duty for military personnel. The study will be conducted over 2 years, from September 1, 2023 to August 31, 2025, in San...